What reviewers say about Integromics
What does Integromics do?
Integromics develops software solutions for Life Sciences, focused on Genomics and Proteomics, that help scientists organize data, perform advanced analyses, and discover biomedical knowledge. The company operates in the global Life Sciences market and also works in the bioinformatics and personalized genomics clinical areas.
What are the most common complaints about Integromics?
Based on the critical reviewers, the most common complaints are not clearly identifiable, as the three lowest-rated reviews on file are all 3-star reviews and their excerpts read as positive rather than critical, describing satisfaction with the software and customer support.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Integromics
Integromics (ITG) develops state-of-the-art software solutions for Life Sciences (Genomics and Proteomics) that enable scientists to effectively organize their data, perform advanced validated analyses, and discover new biomedical knowledge. ITG operates in the global Life Sciences market and has established a network of collaborations and partnerships that has enabled it to access the top-league of players in its sector, as proven by the names of its corporate clients, such as Pfizer, Novartis, Unilever, Merck, Sanofi-Aventis, and Amgen or institutional customers like ETH Zürich, Harvard Medical School, Chinese University of Hong Kong to cite only a few. Since its foundation in 2002, ITG has performed a spectacular, though organic, growth and is currently in a position to further embrace, not only the high-potential bioinformatics market and to consolidate its presence as a leading brand in the Life Sciences community, but also to expand in the personalized genomics clinical market.
- Website
- integromics.com
- [email protected]
- Categories
- Biotechnology
